Novartis
GSK to take control of Consumer Healthcare in £9.2bn buyout
March 27, 2018Manufacturing and Production, Sales and Marketing Consumer Health Care, GSK, Novartis, biotech, drugs, horlicks, pharma, pharmaceutical
GSK has announced that it plans to purchase Novartis’ 36.5% stake in the joint Consumer Healthcare Business for a sum …
Top Ten most popular articles on Pharmafile.com this week
March 23, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canada, Celgene, Lundbeck, Marijuana, Novartis, Roche, Vertex, brexit, cannabis, multiple sclerosis, neuroscience, pharma
As me move startlingly quickly towards Easter, it’s time for another Top Ten rundown. This week, Celgene surprised the industry …
Novartis steps into the medical marijuana business
March 20, 2018Manufacturing and Production, Sales and Marketing Medical marijuana, Novartis, Sandoz, biotech, drugs, pharma, pharmaceutical
Canada’s burgeoning medical marijuana industry has finally drawn in a big pharma player. Tilray, a producer of medical cannabis products, …
Top Ten most popular articles on Pharmafile.com this week
March 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Andrew Witty, AstraZeneca, BMS, Biocon, Martin Shkreli, Novartis, Right to try, US, pharma, top ten
Another week goes by, and we may have finally reached Spring here in the UK. Friday means its time for …
Novartis reshuffle begins under new CEO
March 13, 2018Manufacturing and Production, Medical Communications Novartis, biotech, digital, drugs, pharma, pharmaceutical
It’s a common strategy that newly appointed CEOs will try to change the direction of the company via rejigging leadership …
Novartis forms a Pear to develop mobile therapies
March 2, 2018Medical Communications, Research and Development Novartis, Pear Therapeutics, biotech, drugs, pharma, pharmaceutical
Novartis has announced an agreement between Pear Therapeutics and itself to develop two digital therapeutics, one in schizophrenia and one …
Greek parliament moves to investigate 10 politicians
February 22, 2018Medical Communications, Sales and Marketing Greece, Greek Parliament, Novartis, biotech, drugs, pharma, pharmaceutical
After a 20-hour debate, Greek parliament has voted in favour of investigating 10 politicians named as part of an investigation …
Lilly posts promising P3 Taltz data
February 14, 2018Research and Development Cosentyx, Eli Lilly, IL-17, Novartis, Taltz, biotech, drugs, pharma, pharmaceutical
The IL-17 market is a crowded space, and one dominated by Novartis’ Cosentyx. Eli Lilly is attempting to challenge that, …
Top Ten most popular articles on Pharmafile.com this week
February 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Allergan, Antibiotics, Avycaz, Elastagen, FDA, GSK, India, J&J, JJ, Nektar Therapeutics, Novartis, Theravance, artificial intelligence, pharma
It’s top ten time again. This week, among our most popular stories was the worrying news that, accoridng to research …
Stada poaches Novartis exec for fifth CEO in two years
February 8, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, Stada, appointment
Stada has revealed its new CEO as Peter Goldschmidt, the current head of North American operations at Novartis’ generics and …
Novartis tastes own medicine, Advair generic delayed
February 8, 2018Sales and Marketing FDA, Novartis, biotech, drugs, pharma, pharmaceutical
Novartis had not been frontrunner to receive approval for its generic version of GSK’s Advair – lagging behind Mylan’s generic …
New breakthrough for CGRP migraine treatments
February 6, 2018Research and Development Allergan, Amgen, CGRP, Novartis, biotech, drugs, pharma, pharmaceutical
Allergan had a rough year in 2017, dropping by close to $80 a share from February 2017 to this month. …
Two former Greek PMs implicated in Novartis bribery case
February 6, 2018Manufacturing and Production, Medical Communications Greece, Novartis, biotech, drugs, pharma, pharmaceutical
An ongoing investigated case into Novartis sales practices in Greece has so far implicated 10 current and former politicians. The …
Radioactive drug given approval by the FDA
January 29, 2018Sales and Marketing Advanced Accelerator Applications, Lutathera, Novartis, biotech, drugs, pharma, pharmaceutical
The FDA has approved Lutathera, marking the first time that the agency has given approval for a radioactive drug or …
Spark hands over Luxturna rights outside US to Novartis for $170m
January 25, 2018Sales and Marketing Luxturna, Novartis, Spark Therapeutics, pharma
Novartis has confirmed a deal worth a potential $170 million with Spark Therapeutics to develop and commercialise its gene therapy …
Latest content
FibroFind appoints Lee Borthwick as CEO
